(object) array( 'id' => '1467661', 'url' => 'SR/Paxil', 'image' => '', 'title' => 'Paxil', 'tags' => array ( 0 => 'Paxil', 1 => 'Pharmaceutical', 2 => '', ), 'term' => 'Paxil', 'source_id' => 31158, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'lastedit' => '20110709210510', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'lek koji se koristi u lečenju depresije', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603999386894336, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'Paxil', 'Definition' => 'a prescription drug used to treat depression', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Revision User' => 'PetriDish', 'Revision Date' => '2010/05/26', 'Creation User' => 'PetriDish', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Paxil', )

(object) array( 'id' => '1460561', 'url' => 'SR/thrombolytic_therapy', 'image' => '', 'title' => 'trombolitička terapija', 'tags' => array ( 0 => 'trombolitička terapija', 1 => 'Pharmaceutical', 2 => 'Drugs', 3 => '', ), 'term' => 'trombolitička terapija', 'source_id' => 1047729, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Drugs', ), 'lastedit' => '20110705074502', 'part_of_speech' => 'other', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Upotreba lekova u cilju razbijanja ili rastvaranja krvnih ugrušaka, koji su glavni uzrok i srčanog i moždanog udara.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603964533276677, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'thrombolytic therapy', 'Definition' => 'Use of drugs to break up or dissolve blood clots, which are the main cause of both heart attacks and stroke.', 'Part of Speech' => 'other', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Drugs', 'Creation User' => 'CCTRADUCTION', 'Creation Date' => '2011/4/13', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'thrombolytic_therapy', )

(object) array( 'id' => '1461320', 'url' => 'SR/market_positioning', 'image' => '', 'title' => 'pozocioniranje na tržištu', 'tags' => array ( 0 => 'pozocioniranje na tržištu', 1 => 'Business services', 2 => 'Marketing', 3 => '', ), 'term' => 'pozocioniranje na tržištu', 'source_id' => 57180, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Marketing', ), 'lastedit' => '20110705225508', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Pokušaj izdvajanja proizvoda od drugih konkurentskih sličnim njemu, stvarajući utisak o jedinstvenosti.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967784910848, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'market positioning', 'Definition' => 'An attempt to distinguish a product from its similar competitors by creating a perception of uniqueness.', 'Domain' => 'Documentation', 'Industry' => 'Business services', 'Part of Speech' => 'noun', 'Product Category' => 'Marketing', 'Usage Status' => 'New', 'Revision User' => 'Acrovo', 'Revision Date' => '2010/6/18', 'Creation User' => 'Acrovo', 'Creation Date' => '2010/6/18', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'market_positioning', )

(object) array( 'id' => '1461050', 'url' => 'SR/phase_iv_trials', 'image' => '', 'title' => 'Četvrta faza ispitivanja', 'tags' => array ( 0 => 'Četvrta faza ispitivanja', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Četvrta faza ispitivanja', 'source_id' => 30919, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705155512', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Postmarketinške studije za prezentovanje dodatnih informacija uključujući rizike leka, koristi i optimalna upotreba.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966609457152, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'phase iv trials', 'Definition' => 'Post-marketing studies to delineate additional information including the drug\'s risks, benefits, and optimal use.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'phase_iv_trials', )

(object) array( 'id' => '1461301', 'url' => 'SR/benefits', 'image' => '', 'title' => 'benefit', 'tags' => array ( 0 => 'benefit', 1 => 'Business services', 2 => 'Human resources', 3 => '', ), 'term' => 'benefit', 'source_id' => 40068, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Human resources', ), 'lastedit' => '20110705222505', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'posebne povoljnosti za zaposlene npr. plaćeno zdravstveno osiguranje', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967781765120, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'benefits', 'Definition' => 'Extra advantages offered to employees e.g. paid health insurance.', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Product Category' => 'Human resources', 'Industry' => 'Business services', 'Revision User' => 'Robert Derbyshire', 'Revision Date' => '2010/6/8', 'Creation User' => 'Robert Derbyshire', 'Creation Date' => '2010/6/8', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'benefits', )

(object) array( 'id' => '1467656', 'url' => 'SR/Lamisil', 'image' => '', 'title' => 'Lamisil', 'tags' => array ( 0 => 'Lamisil', 1 => 'Pharmaceutical', 2 => '', ), 'term' => 'Lamisil', 'source_id' => 31149, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'lastedit' => '20110709210504', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'antibiotik koji se koristi u lečenju gljivičnog oboljenja noktiju na prstima stopala', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603999385845762, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'Lamisil', 'Definition' => 'an antibiotic used to treat toenail fungus', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Revision User' => 'PetriDish', 'Revision Date' => '2010/05/26', 'Creation User' => 'PetriDish', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Lamisil', )

(object) array( 'id' => '1461051', 'url' => 'SR/prevention_trials', 'image' => '', 'title' => 'Ipitivanja prevencije', 'tags' => array ( 0 => 'Ipitivanja prevencije', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Ipitivanja prevencije', 'source_id' => 30922, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705155513', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Odnosi se na ispitivanja koja za cilj imaju pronalaženje boljih načina za prevenciju bolesti kod ljudi koji nikada nisu oboljevali ili prevenciju povratka bolesti. Ovi pristupi mogu podrazumevati lekove, vakcine, vitamine, minerale ili promene načina života.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966610505728, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'prevention trials', 'Definition' => 'Refers to trials to find better ways to prevent disease in people who have never had the disease or to prevent a disease from returning. These approaches may include medicines, vaccines, vitamins, minerals, or lifestyle changes.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'prevention_trials', )

(object) array( 'id' => '1461300', 'url' => 'SR/business_casual', 'image' => '', 'title' => 'poslovno ležerni (stil)', 'tags' => array ( 0 => 'poslovno ležerni (stil)', 1 => 'Business services', 2 => 'Human resources', 3 => '', ), 'term' => 'poslovno ležerni (stil)', 'source_id' => 40066, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Human resources', ), 'lastedit' => '20110705222503', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Standardni stil oblačenja (dress code) u većini firmi, kojim se zadržava profesionalna atmosfera a uz to i zaposleni se osećaju udobno.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967779667968, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'business casual', 'Definition' => 'The standard dress code in most offices, which preserves a professional atmosphere while ensuring that employees are comfortable.', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Product Category' => 'Human resources', 'Industry' => 'Business services', 'Revision User' => 'Robert Derbyshire', 'Revision Date' => '2010/6/8', 'Creation User' => 'Robert Derbyshire', 'Creation Date' => '2010/6/8', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'business_casual', )

(object) array( 'id' => '1460563', 'url' => 'SR/approved_drugs', 'image' => '', 'title' => 'odobreni lekovi', 'tags' => array ( 0 => 'odobreni lekovi', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'odobreni lekovi', 'source_id' => 30872, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705074505', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'U Sjedinjenim Državama, Zavod za zaštitu zdravlja (FDA) mora odobriti supstancu kao lek pre nego bude pušten na tržište. Ovaj proces podrazumeva nekoliko stadijuma uključujući prekliničke laboratorijske studije i studije na životinjama, kliničko testiranje bezbednosti i efikasnosti proizvoda, popunjavanje Prijuave za registraciju novog leka od strane proizvođača samog leka, pregled prijave od strane FDA i odobrenje/odbijanje prijave od strane FDA', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603964534325249, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'approved drugs', 'Definition' => 'In the U.S., the Food and Drug Administration (FDA) must approve a substance as a drug before it can be marketed. The approval process involves several steps including pre-clinical laboratory and animal studies, clinical trials for safety and efficacy, filing of a New Drug Application by the manufacturer of the drug, FDA review of the application, and FDA approval/rejection of application.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'approved_drugs', )

(object) array( 'id' => '1467655', 'url' => 'SR/Lamictal', 'image' => '', 'title' => 'Lamictal', 'tags' => array ( 0 => 'Lamictal', 1 => 'Pharmaceutical', 2 => '', ), 'term' => 'Lamictal', 'source_id' => 31148, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'lastedit' => '20110709210502', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'lek koji se koristi u lečenju epilepsije', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603999385845761, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'Lamictal', 'Definition' => 'a prescription drug used to treat epilepsy', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Revision User' => 'PetriDish', 'Revision Date' => '2010/05/26', 'Creation User' => 'PetriDish', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Lamictal', )